JP2021073174A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021073174A5 JP2021073174A5 JP2020209139A JP2020209139A JP2021073174A5 JP 2021073174 A5 JP2021073174 A5 JP 2021073174A5 JP 2020209139 A JP2020209139 A JP 2020209139A JP 2020209139 A JP2020209139 A JP 2020209139A JP 2021073174 A5 JP2021073174 A5 JP 2021073174A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- amino acid
- binding
- protein according
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023001177A JP7456024B2 (ja) | 2015-01-12 | 2023-01-06 | Il-17a結合ポリペプチド |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15150786 | 2015-01-12 | ||
| EP15150786.0 | 2015-01-12 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017535976A Division JP6943764B2 (ja) | 2015-01-12 | 2016-01-12 | Il−17a結合ポリペプチド |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023001177A Division JP7456024B2 (ja) | 2015-01-12 | 2023-01-06 | Il-17a結合ポリペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021073174A JP2021073174A (ja) | 2021-05-13 |
| JP2021073174A5 true JP2021073174A5 (cg-RX-API-DMAC10.html) | 2021-11-25 |
| JP7208963B2 JP7208963B2 (ja) | 2023-01-19 |
Family
ID=52339024
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017535976A Active JP6943764B2 (ja) | 2015-01-12 | 2016-01-12 | Il−17a結合ポリペプチド |
| JP2020209139A Active JP7208963B2 (ja) | 2015-01-12 | 2020-12-17 | Il-17a結合ポリペプチド |
| JP2023001177A Active JP7456024B2 (ja) | 2015-01-12 | 2023-01-06 | Il-17a結合ポリペプチド |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017535976A Active JP6943764B2 (ja) | 2015-01-12 | 2016-01-12 | Il−17a結合ポリペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023001177A Active JP7456024B2 (ja) | 2015-01-12 | 2023-01-06 | Il-17a結合ポリペプチド |
Country Status (19)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY37651A (es) * | 2017-03-31 | 2018-10-31 | Swedish Orphan Biovitrum Ab Publ | Polipéptido de unión al il-1r-i |
| CN108949789A (zh) * | 2018-06-26 | 2018-12-07 | 山东兴瑞生物科技有限公司 | 抗gcc的核酸、其制备方法、具有该核酸的免疫细胞及其应用 |
| JP7525499B2 (ja) * | 2019-01-31 | 2024-07-30 | ヌマブ セラピューティクス アクチェンゲゼルシャフト | TNFα及びIL-17Aに対する特異性を有する多重特異性抗体、IL-17Aを標的とする抗体、及びそれらの使用方法 |
| WO2021089695A1 (en) * | 2019-11-05 | 2021-05-14 | Affibody Ab | Polypeptides |
| CN111856029B (zh) * | 2020-06-19 | 2023-09-26 | 北华大学 | Il-17a蛋白在膀胱癌中的应用 |
| MX2024009732A (es) * | 2022-02-08 | 2024-08-19 | Affibody Ab | Variantes de la proteina z que enlazan la linfopoyetina estromal timica y su uso medico. |
| US20260028397A1 (en) | 2022-04-07 | 2026-01-29 | Acelyrin, Inc. | Methods of treating ankylosing spondylitis |
| WO2023196916A1 (en) * | 2022-04-07 | 2023-10-12 | Acelyrin, Inc. | Methods of treating of hidradenitis suppurativa |
| EP4704911A1 (en) * | 2023-05-04 | 2026-03-11 | Affibody AB | New polypeptide |
| CN116466095B (zh) * | 2023-06-15 | 2023-09-01 | 朗肽生物制药股份有限公司 | 一种多肽及其应用 |
| EP4773985A1 (en) * | 2023-09-08 | 2026-07-15 | Affibody AB | Methods of treating hidradenitis suppurativa |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0417487D0 (en) | 2004-08-05 | 2004-09-08 | Novartis Ag | Organic compound |
| GB0524788D0 (en) | 2005-12-05 | 2006-01-11 | Affibody Ab | Polypeptides |
| PL1963368T6 (pl) | 2005-12-13 | 2021-02-08 | Eli Lilly And Company | Przeciwciała anty-IL-17 |
| JP2010515463A (ja) | 2007-01-12 | 2010-05-13 | シー レーン バイオテクノロジーズ, エルエルシー | 配座的に束縛されたポリペプチド配列のコンビナトリアルライブラリー |
| DE08786222T1 (de) | 2007-07-31 | 2010-11-25 | Affibody Ab | Neue albuminbindende zusammensetzungen, verfahren und anwendungen |
| ES2373832T3 (es) | 2007-12-19 | 2012-02-09 | Affibody Ab | Polipéptido derivado de proteína a y capaz de unirse a pdgf. |
| NZ594514A (en) * | 2009-03-05 | 2013-06-28 | Abbott Lab | Interleukin-17 BINDING PROTEINS |
| CA2772162C (en) * | 2009-08-27 | 2018-05-22 | Covagen Ag | Anti-il-17a fynomers and medical uses thereof |
| WO2011110515A1 (en) * | 2010-03-08 | 2011-09-15 | Affibody Ab | Immunoglobulin g fc region binding polypeptide |
| BR112013000452A2 (pt) | 2010-07-09 | 2020-02-11 | Affibody Ab | Polipeptídeo de ligação de albumina, proteína de fusão ou conjugado, polinucleotídeo, método para produzir um polipeptídeo, composição, método para a preparação de uma composição, e, método para aumentar a solubilidade de um composto |
| WO2012125680A1 (en) | 2011-03-16 | 2012-09-20 | Novartis Ag | Methods of treating vasculitis using an il-17 binding molecule |
| EP2597102A1 (en) * | 2011-11-25 | 2013-05-29 | Covagen AG | A novel fusion protein comprising an antibody light chain and a polypeptide binding to IL-17 |
| KR102149028B1 (ko) * | 2012-02-20 | 2020-08-27 | 스위디쉬 오르펀 바이오비트럼 에이비 (피유비엘) | 인간 보체 c5에 결합하는 폴리펩티드 |
| EP2711016A1 (en) * | 2012-09-21 | 2014-03-26 | Covagen AG | Novel IL-17A binding molecules and medical uses thereof |
| US10155792B2 (en) | 2012-09-25 | 2018-12-18 | Affibody Ab | Albumin binding polypeptide |
| PL2912054T3 (pl) | 2012-10-25 | 2017-11-30 | Affibody Ab | Polipeptyd wiążący albuminę |
| WO2014113804A1 (en) * | 2013-01-21 | 2014-07-24 | Abbvie Inc. | Anti-tnf and anti-il17 combination therapy biomarkers for inflammatory disease |
| MX366425B (es) * | 2013-03-15 | 2019-07-04 | Affibody Ab | Nuevos polipeptidos. |
| WO2015091957A1 (en) | 2013-12-20 | 2015-06-25 | Affibody Ab | Engineered albumin binding polypeptide |
-
2016
- 2016-01-12 KR KR1020247022438A patent/KR20240110106A/ko active Pending
- 2016-01-12 PL PL16700424T patent/PL3245224T3/pl unknown
- 2016-01-12 KR KR1020177021726A patent/KR102683288B1/ko active Active
- 2016-01-12 NZ NZ732978A patent/NZ732978A/en unknown
- 2016-01-12 EP EP16700424.1A patent/EP3245224B1/en active Active
- 2016-01-12 EP EP25184869.3A patent/EP4643955A3/en active Pending
- 2016-01-12 US US15/538,890 patent/US10934335B2/en active Active
- 2016-01-12 CN CN201680011379.3A patent/CN108064235A/zh active Pending
- 2016-01-12 CA CA2972683A patent/CA2972683A1/en active Pending
- 2016-01-12 EP EP20180610.6A patent/EP3738976B1/en active Active
- 2016-01-12 RU RU2017127012A patent/RU2749712C2/ru active
- 2016-01-12 JP JP2017535976A patent/JP6943764B2/ja active Active
- 2016-01-12 AU AU2016208161A patent/AU2016208161B2/en active Active
- 2016-01-12 HU HUE16700424A patent/HUE052121T2/hu unknown
- 2016-01-12 WO PCT/EP2016/050456 patent/WO2016113246A1/en not_active Ceased
- 2016-01-12 DK DK16700424.1T patent/DK3245224T3/da active
- 2016-01-12 MY MYPI2017702236A patent/MY188784A/en unknown
- 2016-01-12 MX MX2017008660A patent/MX394167B/es unknown
- 2016-01-12 ES ES16700424T patent/ES2822431T3/es active Active
- 2016-01-12 PT PT167004241T patent/PT3245224T/pt unknown
-
2017
- 2017-06-19 IL IL253004A patent/IL253004B/en active IP Right Grant
- 2017-06-27 ZA ZA2017/04366A patent/ZA201704366B/en unknown
-
2020
- 2020-12-17 JP JP2020209139A patent/JP7208963B2/ja active Active
-
2021
- 2021-02-01 US US17/163,961 patent/US12221464B2/en active Active
-
2023
- 2023-01-06 JP JP2023001177A patent/JP7456024B2/ja active Active
-
2024
- 2024-07-31 US US18/790,379 patent/US20250101074A1/en active Pending